Sign In
Buy A
$137.40
+2.36 (+1.75%)
At Close: Jun 03, 2026
Agilent Reports First-Quarter Fiscal Year 2025 Financial Results
04:04pm, Wednesday, 26'th Feb 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up
Agilent to Report Q1 Earnings: What's in the Cards for the Stock?
02:30pm, Monday, 24'th Feb 2025
A's fiscal first-quarter performance is likely to have been influenced by higher expenses, increased CapEx and the Lunar New Year timing shift.
What Analyst Projections for Key Metrics Reveal About Agilent (A) Q1 Earnings
10:21am, Friday, 21'st Feb 2025
Besides Wall Street's top -and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
05:59pm, Friday, 24'th Jan 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26.
Agilent Automated Workflows at SLAS2025: Connecting with Confidence
08:00am, Friday, 24'th Jan 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Ex
Agilent Rises 11% in a Year: Should You Buy, Sell or Hold the Stock?
02:01pm, Thursday, 16'th Jan 2025
A faces challenges with slowing end-market demand and regulatory hurdles in China, raising growth concerns.
Agilent Technologies, Inc. (A) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)
09:17am, Wednesday, 15'th Jan 2025
Agilent Technologies, Inc. (NYSE:A ) J.P. Morgan 43rd Annual Healthcare Conference January 14, 2025 12:45 PM ET Company Participants Padraig McDonnell - President and CEO Robert McMahon - Senior VP an
Reaves Utility Income Fund Section 19(A) Notice
06:59am, Monday, 30'th Dec 2024
DENVER, CO / ACCESSWIRE / December 30, 2024 / On December 30, 2024, the Reaves Utility Income Fund (NYSE American:UTG) (the "Fund"), a closed-end sector fund, paid a monthly distribution on its common
Agilent (A) Up 1.3% Since Last Earnings Report: Can It Continue?
12:31pm, Wednesday, 25'th Dec 2024
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Is the Options Market Predicting a Spike in Agilent (A) Stock?
09:36am, Monday, 23'rd Dec 2024
Investors need to pay close attention to Agilent (A) stock based on the movements in the options market lately.
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
01:45pm, Thursday, 19'th Dec 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conferen
Agilent investor day calls for margin expansion, says Goldman Sachs
05:45pm, Tuesday, 17'th Dec 2024
Goldman Sachs keeps a Buy rating and $150 price target on Agilent after the company's investor day presentation. The firm's main takeaways from the event are the forecast for operating margin expansio
Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics
05:34pm, Tuesday, 17'th Dec 2024
Padraig McDonnell, Agilent CEO, joins 'Closing Bell Overtime' to talk investors day, its healthcare segment, and more.
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
11:09am, Tuesday, 10'th Dec 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IH
Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?
01:25pm, Monday, 09'th Dec 2024
A's shares ride on the bright performance of the Agilent CrossLab Group segment and strategic acquisitions.
